Expert Opinion on Investigational Drugs

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search
Expert Opinion on Investigational Drugs  
Discipline Pharmacology
Language English
Publication details
Former name(s)
Current Opinion in Investigational Drugs
Publication history
Frequency Monthly
Standard abbreviations
Expert Opin. Investig. Drugs
ISSN 1354-3784 (print)
1744-7658 (web)
OCLC no. 30379431

Expert Opinion on Investigational Drugs is a monthly peer-reviewed medical journal covering developments in pharmaceutical research, from animal studies through to early clinical investigation. The journal's scope includes therapeutics in many areas: pulmonary-allergy, dermatology, gastrointestinal, arthritis, infectious disorders, endocrine and metabolic, central and peripheral nervous system, cardiovascular and renal, and oncology.

The journal was established by Current Drugs in 1992, under the title Current Opinion in Investigational Drugs. In 1994, the journal was acquired by Ashley Publications, who published it until 2015, when it was acquired by Taylor & Francis. The current Editor-in-Chief is Giuseppe Tonini (University Campus Bio-Medico). According to the Journal Citation Reports has a 2014 impact factor of 5.528. It is also indexed in MEDLINE. The journal is available online and in paper format.